![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print October 19, 2004
Deaprtment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536-0298
Corresponding Author: lhersh{at}uky.edu
It has previously been reported that ATP inhibits the insulysin (IDE) reaction (Camberos et al., Exp. Biol. Med. 226, 334-341, 2001). We report here that with Abz-GGFLRKHGQ-EDDnp as substrate, ATP and other nucleotides increase the rate >20 fold in Tris buffer. There is no specificity with respect to the nucleotide, however ATP is more effective than ADP, which is more effective than AMP. Triphosphate itself was as effective as ATP, indicating it is this moiety responsible for activation. The binding of triphosphate was shown to be at a site distinct from the active site, thus acting as a non-competitive activator. With the physiological substrates insulin and amyloid b peptide, nucleotides and triphosphate were without effect. However, with small physiological peptides such a bradykinin and dynorphin B-9, ATP and triphosphate increased the rate of hydrolysis ~10 fold. Triphosphate and ATP shifted the oligomeric state of the enzyme from primarily dimer-tetramers to a monomer. These data suggest the presence of an allosteric regulatory site on insulysin that may that shifts its specificity toward small peptide substrates.
J. Biol. Chem, 10.1074/jbc.M411177200
Submitted on September 29, 2004
Revised on October 19, 2004
Accepted on October 19, 2004
ATP affects on insulin degrading enzyme are mediated primarily through its triphosphate moiety
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Im, M. Manolopoulou, E. Malito, Y. Shen, J. Zhao, M. Neant-Fery, C.-Y. Sun, S. C. Meredith, S. S. Sisodia, M. A. Leissring, et al. Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDE J. Biol. Chem., August 31, 2007; 282(35): 25453 - 25463. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, L. B. Hersh, M. A. Leissring, M. Ingelsson, T. Matsui, W. Farris, A. Lu, B. T. Hyman, D. J. Selkoe, L. Bertram, et al. Decreased Catalytic Activity of the Insulin-degrading Enzyme in Chromosome 10-Linked Alzheimer Disease Families J. Biol. Chem., March 16, 2007; 282(11): 7825 - 7832. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. del Carmen Camberos and J. C. Cresto Insulin-Degrading Enzyme Hydrolyzes ATP Experimental Biology and Medicine, February 1, 2007; 232(2): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Song, A. Daily, M. G. Fried, M. A. Juliano, L. Juliano, and L. B. Hersh Mutation of Active Site Residues of Insulin-degrading Enzyme Alters Allosteric Interactions J. Biol. Chem., May 6, 2005; 280(18): 17701 - 17706. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |